Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters

International Journal of Impotence Research

Volumn 14, Issue 1, 2002, Pages 15-24

  Lin, C S ^a   Chow, S ^a   Lau, A ^a   Tu, R ^a   Lue, T F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alternative first exon; Isoform; PDE5A promoter; Penis; Smooth muscle; Transcription factor

Indexed keywords

CYCLIC AMP; CYCLIC GMP; MESSENGER RNA; PHOSPHODIESTERASE; PHOSPHODIESTERASE V; SILDENAFIL; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATALYSIS; CORPUS CAVERNOSUM; DRUG MECHANISM; EXON; INTRON; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PENIS ERECTION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; COS CELLS; CYCLIC AMP; CYCLIC GMP; EXONS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; ISOENZYMES; MALE; MOLECULAR SEQUENCE DATA; PENIS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

EID: 0036189959     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900802     Document Type: Article

References (30)

1. Therapeutic potential of selective PDE inhibitors in asthma
2. Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: Shifting the focus from inotropy to cyclic adenosine monophosphate
3. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes
4. Cyclic GMP phosphodiesterase-5: Target of sildenafil
5. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
6. Purification of cGMP-binding protein phosphodiesterase from rat lung
7. Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase
8. The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone
9. Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development
10. Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5)
11. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase
12. Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene
13. Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum
14. Identification of three alternative first exons and an intronic promoter of human PDE5A gene
15. The murine L-plastin gene promoter: Identification and comparison with the human L-plastin gene promoter
16. Correction of the N-terminal sequences of the human plastin isoforms by using anchored polymerase chain reaction: Identification of a potential calcium-binding domain
17. pMECA: A cloning plasmid with 44 unique restriction sites that allows selection of recombinants based on colony size
18. DNase footprinting: A simple method for the detection of protein-DNA binding specificity
19. Sequencing end-labeled DNA with base-specific chemical cleavages
20. The scanning model for translation: An update
21. Incorporation of glutamine repeats makes protein oligomerize: Implications for neurodegenerative diseases
22. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression
23. The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma
24. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer
25. Polymorphic CAG repeats of the androgen receptor gene and rheumatoid arthritis
26. Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: Molecular markers of risk for male infertility
27. Etiology of (CAG)n triplet repeat neurodegenerative diseases such as Huntington’s disease is connected to stimulation of glutamate receptors
28. Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene
29. Age-related decrease of protein kinase G activation in vascular smooth muscle cells
30. Characterization of an intronic promoter of a cyclic adenosine 3′, 5′-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility